|
|
| Working & Treatment of
Klotrix – Potassium Chloride |
Klotrix is the registered branded oral medication presented by
Bristol-Myers Squibb Co, formulated by using basic ingredient
Potassium Chloride. The tablet contains 750 mg of Potassium Chloride
equivalent to 10mEq of potassium formulated in the film-coated
wax-matrix tablet form. Klotrix is designed to provide controlled
release of potassium from matrix for minimizing the probabilities of
generating highly restricted concentrations of potassium typically
in the gastrointestinal tract. Klotrix is mineral supplement used
for averting or treating low levels of potassium in the blood. For
proper functioning of cells, nerves, heart, muscles and kidneys
normal levels of potassium in the blood is necessary.
Klotrix is believed to restock the electrolyte. Potassium chloride
emerges as granular powder in white color or colorless, freely
soluble in alcohol and odorless crystals having saline taste and its
solution neutral to litmus. Klotrix is used for treating patients
having hypokalemia with or without metabolic alkalosis in digitalis
intoxication and patients having hypokalemia familial episodic
paralysis. However, the minimal dosage of diuretic should be
prescribed if hypokalemia is due to the diuretic therapy as it could
be enough without leading to hypokalemia.
The drug is also used for averting hypokalemia in vulnerable
patients if hypokalemia were to occur, for instance, digitalized
patients or patients having considerable cardiac arrhythmias. Normal
dietary intake of potassium by an adult is between 50 and 100mEq per
day. Potassium diminution enough for causing hypokalemia generally
needs the loss of 200 or more mEq of potassium from the total
storage in the body. Therefore, dosage of Klotrix must be adjusted
according to the requirement of individual patient but normally in
20mEq per day for averting hypokalemia and between 40 and 100mEq and
more for treating potassium exhaustion in the body.
|
|
